Results for tag: "Breast Cancer Diagnostics"

The Breast Cancer Diagnostics market is a subset of the larger Diagnostics industry. It is focused on the development and commercialization of products and services that aid in the early detection and diagnosis of breast cancer. These products and services include imaging technologies such as mammography, ultrasound, and MRI, as well as biopsy and other tissue sampling techniques. Additionally, the market includes a range of molecular diagnostics, such as gene expression profiling and circulating tumor DNA tests. The Breast Cancer Diagnostics market is driven by the increasing prevalence of breast cancer, as well as the need for early detection and diagnosis. Additionally, technological advancements in imaging and molecular diagnostics have enabled the development of more accurate and cost-effective tests. Notable companies in the Breast Cancer Diagnostics market include Hologic, GE Healthcare, Siemens Healthineers, Philips, and Roche Diagnostics. Show Less Read more